Bioengineering

Stanford Medicine scientists describe details of the human intestine and placental tissue as part of the National Institute of Health’s Human Biomolecular Atlas Program.

The program will translate scientific discoveries out of the lab and into clinical and commercial applications.

Scientists gathered to discuss the future of synthetic biology and how it can help curb climate change and promote sustainability.

A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.

Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.

The Stanford psychiatrist, neuroscientist and engineer is honored for developing a technology that lets researchers pinpoint the functions — and malfunctions — of specific brain circuits.

A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.

A Stanford scientist and his colleagues show that patients fitted with a chip in their eye are able to integrate what the chip “sees” with objects their natural peripheral vision detects.